Eric Racine is the director of the Neuroethics Research Unit and associate research professor at the IRCM (Institut de recherches cliniques de Montréal). He also holds academic appointments at the University of Montreal (Bioethics and Medicine) and McGill University (Neurology and Neurosurgery and Bioethics). The author of Pragmatic Neuroethics, Racine is a pioneer researcher in neuroethics and a prolific author of peer-reviewed papers, chapters, and columns published in leading bioethics, neuroscience, social science, and medical journals. He is a member of the advisory board of the Institute for Neurosciences, Mental Health and Addiction of the Canadian Institutes of Health Research; member of the DANA Alliance for Brain Initiatives; and associate editor of the journal Neuroethics. He has been involved in seminal events and international conferences in neuroethics. He was a visiting fellow at the Brocher Foundation (Switzerland), the International Institute of Biomedical Ethics at Uppsala University (Sweden), and the Center for Advanced Studies at the University of Munich (Germany).
More About Eric Racine
Physicians should consider competing obligations, such as the need for evidence of benefit and upholding equitable and prudent use of resources as well as professional integrity, when prescribing smart drugs.
Research into the efficacy and safety of cognitive enhancers for recreational or lifestyle use has not been done. Should society pay for studies that might improve the lives of already healthy people?
Positive portrayals of smart drugs in media and medical research will entice more people to use smart drugs. Medical professionals and society need to prepare for more prevalent non-medical uses of neuropharmaceuticals by fostering better informed public debates.